5 March 2015 3:30 – 6 pm
MGSM Conference Centre
99 Talavera Road, Macquarie Park
Mendel Grobler (Director – Strategic Access and Policy, Pfizer) will be speaking about the Pharmaceutical Benefit Scheme and the challenges of providing Australian patients with innovative medicines in a talk titled
The Pharmaceutical Benefits Scheme: Bent, overspent or just spent?
3:30 – 3:45 pm Registration and Refreshments
3:45 – 5:00 pm Mendel Grobler (Director – Strategic Access and Policy, Pfizer)
5:00 – 6:00 pm Networking Drinks
About Mendel Grobler
Mendel Grobler is the Director, Strategic Access and Policy at Pfizer Australia (Pty Ltd) and is responsible in this role for Australia and New Zealand, as well as advising Pfizer Inc. on regional and global approaches to Health Technology Assessment.
He has been working in the field of health care funding and financing for more than twenty years and has extensive experience across the pharmaceutical industry including manufacture, product development, registration, distribution and community/hospital pharmacy. He has previously represented the industry on the Economic Sub-Committee of PBAC and also served as advisor to the Australian Department of Veterans’ Affairs. Over the past few years he has accepted invitations to contribute to various government- industry discussions about equitable funding policy in Korea, China and Taiwan.
He has published a number of research papers in peer-reviewed and other journals, and delivered presentations at international medical and health economic conferences. He is a member of the Australian Health Economics Society, the International Health Economics Association and Health Technology Association International.